Viking Therapeutics (VKTX) Tops Q4 EPS by 3c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Alzamend Neuro lithium trial data accepted for Barcelona MRI workshop
• HawkEye 360 wins NRO contract for commercial RF data services